NASDAQ:JAZZ
Jazz Pharmaceuticals Plc
- Stock
Last Close
134.06
06/11 21:01
Market Cap
6.45B
Beta: 0.75
Volume Today
1.29M
Avg: 495.45K
PE Ratio
95.39
PFCF: 8.86
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 29.35M - | 24.74M 15.70% | 26.75M 8.11% | 38.65M 44.47% | 48.10M 24.46% | 65.78M 36.76% | 87.00M 32.26% | 584.06M 571.32% | 893.39M 52.96% | ||
average payables | 23.07M - | 23.47M 1.74% | 22.11M 5.78% | 23.39M 5.79% | 32.48M 38.88% | 44.07M 35.67% | 37.24M 15.49% | 63.62M 70.82% | 95.53M 50.15% | ||
average receivables | 155.59M - | 198.03M 27.28% | 221.96M 12.09% | 229.19M 3.25% | 243.98M 6.46% | 309.91M 27.02% | 376.24M 21.40% | 479.93M 27.56% | 607.43M 26.57% | ||
book value per share | 22.95 - | 26.11 13.76% | 31.03 18.85% | 45.20 45.68% | 45.98 1.70% | 54.82 19.24% | 65.69 19.83% | 66.43 1.12% | 49.34 25.72% | ||
capex per share | -4.00 - | -0.59 85.32% | -3.00 411.09% | -1.90 36.74% | -2.19 15.46% | -3.21 46.58% | -6.81 111.87% | -0.76 88.80% | -7.97 944.39% | ||
capex to depreciation | -1.79 - | -0.33 81.38% | -1.60 379.58% | -0.69 56.77% | -0.61 12.08% | -0.49 18.80% | -1.36 176.70% | -0.08 93.95% | -0.79 860.34% | ||
capex to operating cash flow | -0.59 - | -0.07 88.52% | -0.31 354.88% | -0.16 46.53% | -0.16 0.09% | -0.23 42.71% | -0.42 79.50% | -0.06 86.13% | -0.39 569.68% | ||
capex to revenue | -0.20 - | -0.03 86.68% | -0.12 349.61% | -0.07 42.31% | -0.07 1.23% | -0.08 21.31% | -0.16 90.24% | -0.01 90.83% | -0.14 825.19% | ||
cash per share | 11.45 - | 16.15 41.04% | 7.04 56.40% | 10.01 42.23% | 13.75 37.30% | 18.98 38.08% | 38.28 101.65% | 9.91 74.12% | 14.09 42.26% | ||
days of inventory on hand | 93.37 - | 69.25 25.84% | 117.93 70.31% | 143.25 21.47% | 159.03 11.01% | 224.28 41.03% | 233.82 4.25% | 888.34 279.93% | 482.19 45.72% | ||
days payables outstanding | 78.11 - | 77.63 0.60% | 77.63 0.00% | 80.72 3.98% | 121.93 51.05% | 135.65 11.25% | 66.04 51.31% | 83.06 25.76% | 61.29 26.21% | ||
days sales outstanding | 58.00 - | 57.77 0.39% | 57.46 0.54% | 50.54 12.05% | 50.93 0.77% | 60.11 18.02% | 61.23 1.87% | 66.45 8.53% | 64.98 2.22% | ||
debt to assets | 0.40 - | 0.36 10.83% | 0.42 17.93% | 0.31 27.02% | 0.31 0.58% | 0.32 3.48% | 0.34 7.70% | 0.50 45.94% | 0.53 7.20% | ||
debt to equity | 0.98 - | 0.75 23.04% | 1.08 43.49% | 0.58 46.10% | 0.58 0.65% | 0.57 2.37% | 0.61 8.03% | 1.55 153.45% | 1.88 21.36% | ||
dividend yield | |||||||||||
earnings yield | 0.01 - | 0.04 541.48% | 0.06 57.12% | 0.06 0.34% | 0.06 0.38% | 0.06 2.73% | 0.03 58.00% | -0.04 266.69% | -0.02 50.31% | 0.05 317.74% | |
enterprise value | 10.44B - | 8.82B 15.50% | 8.26B 6.38% | 9.28B 12.31% | 8.72B 5.98% | 9.59B 9.99% | 10.37B 8.13% | 13.15B 26.79% | 14.88B 13.13% | ||
enterprise value over ebitda | 18.51 - | 13.83 25.27% | 11.51 16.75% | 12.11 5.19% | 10.15 16.19% | 9.62 5.22% | 10.12 5.19% | 18.89 86.71% | 13.39 29.15% | ||
ev to operating cash flow | 25.73 - | 16.59 35.54% | 13.99 15.67% | 13.38 4.31% | 10.92 18.44% | 12.36 13.18% | 11.53 6.68% | 16.89 46.51% | 11.70 30.76% | ||
ev to sales | 8.90 - | 6.66 25.19% | 5.55 16.64% | 5.73 3.24% | 4.61 19.52% | 4.44 3.79% | 4.39 1.10% | 4.25 3.15% | 4.07 4.34% | ||
free cash flow per share | 2.79 - | 8.10 190.15% | 6.76 16.55% | 9.65 42.75% | 11.13 15.33% | 10.47 5.93% | 9.34 10.77% | 12.28 31.45% | 12.37 0.77% | 15.15 22.47% | |
free cash flow yield | 0.02 - | 0.06 237.98% | 0.06 7.58% | 0.07 15.59% | 0.09 25.27% | 0.07 21.89% | 0.06 19.30% | 0.10 70.30% | 0.08 19.42% | 0.12 58.62% | |
graham net net | -18.90 - | -9.88 47.69% | -38.09 285.32% | -26.99 29.14% | -23.29 13.69% | -18.40 21.00% | -7.15 61.15% | -113.63 1,489.33% | -96.30 15.25% | ||
graham number | 22.46 - | 56.23 150.30% | 67.67 20.36% | 90.93 34.36% | 87.81 3.42% | 106.66 21.46% | 79.56 25.40% | 90.75 14.06% | 61.65 32.06% | ||
income quality | 7.08 - | 1.61 77.19% | 1.49 7.81% | 1.42 4.53% | 1.79 25.77% | 1.48 16.98% | 3.77 154.15% | -2.36 162.63% | -5.68 140.40% | ||
intangibles to total assets | 0.64 - | 0.55 14.43% | 0.81 48.35% | 0.77 5.81% | 0.70 8.25% | 0.61 13.71% | 0.48 20.49% | 0.73 51.34% | 0.69 5.36% | 0 100% | |
interest coverage | 3.71 - | 8.93 140.65% | 9.55 6.97% | 6.80 28.80% | 7.98 17.29% | 7.37 7.64% | 7.68 4.20% | 0.61 92.04% | 1.78 190.95% | -2.00 212.48% | |
interest debt per share | 23.35 - | 20.60 11.78% | 34.57 67.82% | 27.64 20.05% | 27.90 0.96% | 32.26 15.62% | 41.90 29.89% | 107.48 156.49% | 97.29 9.48% | ||
inventory turnover | 3.91 - | 5.27 34.84% | 3.09 41.28% | 2.55 17.67% | 2.30 9.92% | 1.63 29.09% | 1.56 4.08% | 0.41 73.68% | 0.76 84.23% | ||
invested capital | 0.98 - | 0.75 23.04% | 1.08 43.49% | 0.58 46.10% | 0.58 0.65% | 0.57 2.37% | 0.61 8.03% | 1.55 153.45% | 1.88 21.36% | ||
market cap | 9.78B - | 8.61B 12.02% | 6.60B 23.36% | 8.08B 22.51% | 7.43B 8.00% | 8.47B 13.95% | 9.20B 8.54% | 7.61B 17.29% | 9.96B 31.01% | 8.86B 11.03% | |
net current asset value | -951.90M - | -503.35M 47.12% | -2.17B 332.07% | -1.44B 33.68% | -1.21B 15.96% | -797.65M 34.19% | -36.59M 95.41% | -5.72B 15,539.32% | -5.14B 10.11% | ||
net debt to ebitda | 1.17 - | 0.34 71.02% | 2.32 585.76% | 1.56 32.72% | 1.50 4.01% | 1.12 24.92% | 1.15 2.14% | 7.97 593.82% | 4.42 44.50% | ||
net income per share | 0.98 - | 5.38 450.70% | 6.56 21.88% | 8.13 23.92% | 7.45 8.29% | 9.22 23.72% | 4.28 53.56% | -5.51 228.66% | -3.42 37.86% | 5.76 268.11% | |
operating cash flow per share | 6.79 - | 8.69 27.91% | 9.76 12.36% | 11.55 18.31% | 13.32 15.35% | 13.68 2.71% | 16.15 18.03% | 13.04 19.24% | 20.34 55.95% | 15.15 25.50% | |
payables turnover | 4.67 - | 4.70 0.61% | 4.70 0.00% | 4.52 3.82% | 2.99 33.80% | 2.69 10.12% | 5.53 105.40% | 4.39 20.49% | 5.96 35.52% | ||
receivables turnover | 6.29 - | 6.32 0.39% | 6.35 0.54% | 7.22 13.69% | 7.17 0.76% | 6.07 15.27% | 5.96 1.83% | 5.49 7.86% | 5.62 2.27% | ||
research and ddevelopement to revenue | 0.07 - | 0.10 40.57% | 0.11 6.84% | 0.12 12.40% | 0.12 2.24% | 0.14 15.69% | 0.14 2.34% | 0.16 15.19% | 0.16 1.28% | 0.11 29.59% | |
return on tangible assets | 0.05 - | 0.22 346.04% | 0.44 104.23% | 0.41 8.14% | 0.29 28.97% | 0.24 16.98% | 0.07 70.64% | -0.10 240.51% | -0.06 35.48% | ||
revenue per share | 19.63 - | 21.64 10.21% | 24.59 13.68% | 26.97 9.66% | 31.53 16.90% | 38.09 20.82% | 42.42 11.37% | 51.83 22.18% | 58.51 12.88% | 53.20 9.07% | |
roe | 0.04 - | 0.21 384.08% | 0.21 2.54% | 0.18 14.93% | 0.16 9.83% | 0.17 3.76% | 0.07 61.24% | -0.08 227.24% | -0.07 16.35% | ||
roic | 0.03 - | 0.14 402.70% | 0.11 17.57% | 0.14 20.81% | 0.12 12.20% | 0.12 2.73% | 0.11 9.52% | 0.05 56.26% | 0.03 32.54% | ||
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 22.95 - | 26.11 13.76% | 31.03 18.85% | 45.20 45.68% | 45.98 1.70% | 54.82 19.24% | 65.69 19.83% | 66.43 1.12% | 49.34 25.72% | ||
stock based compensation to revenue | 0.06 - | 0.07 16.39% | 0.07 3.94% | 0.07 0.51% | 0.05 17.97% | 0.05 5.59% | 0.05 0.09% | 0.06 19.32% | 0.06 0.68% | ||
tangible asset value | -768.94M - | -244.10M 68.26% | -2.03B 731.00% | -1.21B 40.17% | -901.54M 25.71% | -250.01M 72.27% | 506.39M 302.55% | -5.01B 1,090.29% | -4.40B 12.23% | ||
tangible book value per share | -12.87 - | -3.99 69.03% | -33.53 741.06% | -20.22 39.69% | -15.03 25.66% | -4.41 70.69% | 9.09 306.32% | -84.01 1,024.23% | -70.38 16.22% | ||
working capital | 799.04M - | 1.03B 29.03% | 490.66M 52.41% | 674.33M 37.43% | 888.52M 31.76% | 1.27B 42.46% | 2.19B 72.69% | 1.80B 17.56% | 1.67B 7.16% |
All numbers in USD (except ratios and percentages)